SCHEMBL5633795

SCHEMBL5633795

CCCCN1C(=O)C(=C(N)N)C(=O)N(CC(C)CC)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
EP300 Q09472 1/20 0.31
KDM4E B2RXH2 1/20 0.31
KMT2A Q03164 2/20 0.31
RGS4 P49798 1/20 0.30
RGS8 P57771 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
CYP1A2 P05177 1/20 0.30
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30
THRB P10828 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
ALOX12 P18054 1/20 0.30
CYP2C19 P33261 1/20 0.30
RECQL P46063 1/20 0.30
BLM P54132 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5633422 0.86 MAPT (0.43) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL5634058 0.75 CDC25B (0.37) MAPTALDH1A1CYP2C9CYP2C19L3MBTL1
SCHEMBL5634034 0.74 CDC25B (0.38) MAPTALDH1A1KDM4ECYP2C9HPGD
SCHEMBL5633433 0.74 CDC25B (0.38) MAPTALDH1A1KDM4ECYP2C9HPGD
SCHEMBL30943167 0.73 ALDH1A1 (0.33) MAPTALDH1A1L3MBTL1
SCHEMBL5633394 0.72 ALDH1A1 (0.31) MAPTALDH1A1KMT2AMEN1USP2
SCHEMBL30942848 0.72 ALDH1A1 (0.33) MAPTALDH1A1L3MBTL1
SCHEMBL5633937 0.71 TDP1 (0.54) MAPTALDH1A1KMT2AMEN1USP2
SCHEMBL5633265 0.71 AGTR1 (0.40) MAPTALDH1A1KMT2ACYP1A2L3MBTL1
SCHEMBL5632794 0.70 ALDH1A1 (0.43) MAPTALDH1A1KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123548-A1 Pth agonists COWAN DAVID J 2007-05-31 US claimed
US-20070123548-A1 Pth agonists COWAN DAVID J 2007-05-31 US disclosed
EP-1713782-A1 PTH AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-25 EP disclosed
WO-2005077918-A1 PTH AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123548-A1 Pth agonists PTH1R, SSTR3, CALCR MAPT 4835/4885ALDH1A1 3899/4885EP300 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.